Brucke Financial
AMRX icon

Brucke Financial’s Amneal Pharmaceuticals AMRX Stock Holding History

Brucke Financial’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$294K Sell
14,609
-691
-5% -$12.4K 0.12% 131
2026
Q2 		$265K Buy
15,300
+137
+0.9% +$1.88K 0.12% 134
2026
Q1 		$188K Buy
+15,163
New +$204K 0.1% 162

Other funds holding AMRX

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Tucker Asset Management
Tucker Asset Management Littleton, Colorado $406M AUM 20.49% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Brucke Financial's AMRX Position: Q3 2026 in Review

Brucke Financial reduced its Amneal Pharmaceuticals (AMRX) stake by 4.5% in Q3 2026, selling an estimated $12.4K and leaving 14,609 shares worth $294K. The position accounts for 0.12% of the portfolio, ranked #131.

Brucke Financial first reported a position in AMRX in Q1 2026 and has held it in 3 quarters since. 142 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Brucke Financial held 14,609 shares of Amneal Pharmaceuticals worth $294K as of Q3 2026.
  • Brucke Financial sold 691 Amneal Pharmaceuticals shares in Q3 2026, an estimated $12.4K.
  • Amneal Pharmaceuticals made up 0.12% of Brucke Financial's portfolio in Q3 2026, its #131 holding.
  • Brucke Financial first reported a position in Amneal Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 142 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Brucke Financial's 13F filing for Q3 2026, filed 23 Oct 2026.